Hypoxia-Inducible Factor-1αand CD271 inversely correlate with melanoma invasiveness-Reference-Cited by-同舟云学术

Hypoxia-Inducible Factor-1αand CD271 inversely correlate with melanoma invasiveness

Published:2015-04-27 Issue:5 Volume:24 Page:396-398
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Marconi Alessandra¹,Borroni Riccardo G.¹^ORCID,Truzzi Francesca¹,Longo Caterina²,Pistoni Federica¹,Pellacani Giovanni³,Pincelli Carlo¹

Affiliation:

1. Laboratory of Cutaneous Biology; Department of Surgical, Medical, Dental and Morphological Sciences; University of Modena and Reggio Emilia; Modena Italy

2. Skin Cancer Unit; ASMN-IRCCS; Reggio Emilia Italy

3. Dermatology Unit; Department of Surgical, Medical, Dental and Morphological Sciences; University of Modena and Reggio Emilia; Modena Italy

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/exd.12679/fullpdf

Reference9 articles.

1. HIF Gene Expression in Cancer Therapy

2. HIF1α and HIF2α independently activate SRC to promote melanoma metastases

3. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

4. Neurotrophins and Their Receptors Stimulate Melanoma Cell Proliferation and Migration

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The p75 neurotrophin receptor attenuates secondary thalamic damage after cortical infarction by promoting angiogenesis;CNS Neuroscience & Therapeutics;2024-07

2. PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions;Translational Oncology;2024-04

3. İNVAZİV MELANOMLARDA CD271 VE BRAF EKSPRESYONUNUN KLİNİKOPATOLOJİK PARAMETRELERLE VE PROGNOZ İLE İLİŞKİSİNİN İMMÜNOHİSTOKİMYASAL YÖNTEMLE ARAŞTIRILMASI;SDÜ Tıp Fakültesi Dergisi;2023-06-22

4. 3D Bioprinting: An Enabling Technology to Understand Melanoma;Cancers;2022-07-20

5. BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response;Clinical, Cosmetic and Investigational Dermatology;2022-06